Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design
- DOI
- 10.1016/j.ard.2026.08.006
- Published
- 2026-09
- Container
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ard.2026.08.006,
title = {Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design},
author = {Jörg H.W. Distler and Shervin Assassi and Armando Gabrielli and Yannick Allanore and Lorinda Chung and Maurizio Cutolo and Francesco Del Galdo and Jeska K. De Vries-Bouwstra and Robyn T. Domsic and Muriel Elhai and Tracy Frech and Monique Hinchcliff and Bernhard Homey and Dinesh Khanna and Thomas Krieg and Masataka Kuwana and Alain Lescoat and Andrea H.L. Low and Marco Matucci-Cerinic and Zsuzsanna H. McMahan and Jerry A. Molitor and Luc Mouthon and Mandana Nikpour and Gabriela Riemekasten and Julia Spierings and Marie-Elise Truchetet and Vanessa Smith and John Varga and Elizabeth Volkmann and Madelon C. Vonk and Jiucun Wang and Dong Xu and Honglin Zhu and Anna-Maria Hoffmann-Vold and Christopher P. Denton and Oliver Distler},
year = {2026},
journal = {Annals of the Rheumatic Diseases},
doi = {10.1016/j.ard.2026.08.006},
url = {https://doi.org/10.1016/j.ard.2026.08.006}
}RIS
TY - JOUR TI - Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design AU - Jörg H.W. Distler AU - Shervin Assassi AU - Armando Gabrielli AU - Yannick Allanore AU - Lorinda Chung AU - Maurizio Cutolo AU - Francesco Del Galdo AU - Jeska K. De Vries-Bouwstra AU - Robyn T. Domsic AU - Muriel Elhai AU - Tracy Frech AU - Monique Hinchcliff AU - Bernhard Homey AU - Dinesh Khanna AU - Thomas Krieg AU - Masataka Kuwana AU - Alain Lescoat AU - Andrea H.L. Low AU - Marco Matucci-Cerinic AU - Zsuzsanna H. McMahan AU - Jerry A. Molitor AU - Luc Mouthon AU - Mandana Nikpour AU - Gabriela Riemekasten AU - Julia Spierings AU - Marie-Elise Truchetet AU - Vanessa Smith AU - John Varga AU - Elizabeth Volkmann AU - Madelon C. Vonk AU - Jiucun Wang AU - Dong Xu AU - Honglin Zhu AU - Anna-Maria Hoffmann-Vold AU - Christopher P. Denton AU - Oliver Distler PY - 2026 JO - Annals of the Rheumatic Diseases DO - 10.1016/j.ard.2026.08.006 UR - https://doi.org/10.1016/j.ard.2026.08.006 ER -
APA
Distler, J. H., Assassi, S., Gabrielli, A., Allanore, Y., Chung, L., Cutolo, M., Galdo, F. D., Vries-Bouwstra, J. K. D., Domsic, R. T., Elhai, M., Frech, T., Hinchcliff, M., Homey, B., Khanna, D., Krieg, T., Kuwana, M., Lescoat, A., Low, A. H., Matucci-Cerinic, M., McMahan, Z. H., Molitor, J. A., Mouthon, L., Nikpour, M., Riemekasten, G., Spierings, J., Truchetet, M., Smith, V., Varga, J., Volkmann, E., Vonk, M. C., Wang, J., Xu, D., Zhu, H., Hoffmann-Vold, A., Denton, C. P., & Distler, O. (2026). Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.08.006
Source records
- crossref · retrieved 2026-09-25T12:22:21.095Z